WO2017178587A1 - Procédé de détection universelle et quantification d'adnr de mycoplasma (mollicutes) 16s par réaction en chaîne de la polymérase quantitative en amplifiant un fragment de 1,5 kilobase - Google Patents

Procédé de détection universelle et quantification d'adnr de mycoplasma (mollicutes) 16s par réaction en chaîne de la polymérase quantitative en amplifiant un fragment de 1,5 kilobase Download PDF

Info

Publication number
WO2017178587A1
WO2017178587A1 PCT/EP2017/058928 EP2017058928W WO2017178587A1 WO 2017178587 A1 WO2017178587 A1 WO 2017178587A1 EP 2017058928 W EP2017058928 W EP 2017058928W WO 2017178587 A1 WO2017178587 A1 WO 2017178587A1
Authority
WO
WIPO (PCT)
Prior art keywords
sample
mycoplasma
dna
rdna
qpcr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2017/058928
Other languages
English (en)
Other versions
WO2017178587A9 (fr
Inventor
Denis GERLIER
Bariza BLANQUIER
Audrey JEAN
Isabelle GROSJEAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Ecole Normale Superieure de Lyon
Universite Claude Bernard Lyon 1
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Ecole Normale Superieure de Lyon
Universite Claude Bernard Lyon 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Ecole Normale Superieure de Lyon, Universite Claude Bernard Lyon 1 filed Critical Centre National de la Recherche Scientifique CNRS
Publication of WO2017178587A1 publication Critical patent/WO2017178587A1/fr
Publication of WO2017178587A9 publication Critical patent/WO2017178587A9/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Definitions

  • the present invention relates to a method for universally detecting and quantifying mycoplasma (Mollicutes) 16S rDNA by amplifying a 1.5 kilobase fragment by quantitative polymerase chain reaction.
  • Mycoplasma (Mollicutes) are among the smallest prokaryotes and are characterized by a lack of rigid cell wall. Their abundance in varied plant and animal hosts as well as their easily unnoticed presence favour their surreptitious cohabitation with culture cells from which they mostly benefit owing to their frequent axenic growth requirements. Mycoplasma (Mollicutes) have numerous and variable impacts on cell biology making them a dreadful cause in obscuring the data obtained in cell culture. Indeed, they interfere with cellular gene expression (Olarerin-George, A. O., and J. B. Hogenesch. 2015.
  • the present invention relates to a method for detecting mycoplasma 16S rDNA 1.5 kilobase fragment amplified by quantitative polymerase chain reaction (qPCR).
  • the inventors demonstrate for the first time the amplification of mycoplasma 16S rDNA 1.5 kilobase fragment using qPCR based on real-time polymerase chain reaction.
  • One of the most critical limitation of the qPCR is the DNA fragment length to amplify. Indeed qPCR is usually performed on 100-250 bp long DNA fragments to improve PCR efficiency.
  • the maximum DNA fragment length used in qPCR was recently reported as being 0.8-0.9 kb long (Li, H., J. Chen, M. Zhou, X. Geng, J. Yu, W. Wang, X. E. Zhang, and H. Wei. 2014.
  • the existing qPCR methods thus does not permit the amplification of long DNA fragments.
  • the first aspect of the present invention refers to a method for universal detection and quantification of mycoplasma (Mollicutes) 16S rDNA 1.5 kilobase fragment in a sample comprising contacting said sample with degenerate primers of SEQ ID N°3 and SEQ ID N°4 amplified by PCR or quantitative PCR and using a DNA loading probe.
  • this technique permits the quantitative detection of the presence of mycoplasma strains.
  • sample refers to cell culture extract such as supernatant, to human or animal biological sample, water sample or food sample such as milk for example.
  • 16S rDNA has its general meaning in the art and refers to the gene encoding for ribosomal 16S RNA.
  • the term “16S rDNA gene” refers to nucleic acid sequence SEQ ID N°l as defined below.
  • Genbank accession n°NR_036952.1 Mycoplasma capricolum subsp. capricolum strain California kid 16S ribosomal RNA gene, complete sequence, 1524 bp
  • 16S rDNA gene is present in all Prokaryotes, so it is a useful marker of its presence. It is a conserved gene among prokaryotic cells and presents a functional constancy.
  • the DNA sequence of the 16S rDNA gene has been determined for a large number of species. It is approximatively 1500 base pair long, existing as a multigene family or operons, and codes for a ribosomal 16S RNA.
  • 16S RNA is a catalytic RNA which is part of the 30S unit of the prokaryotic ribosome. 16S DNA gene has strongly conserved sequence regions and variable sequence regions.
  • the nucleotide sequences of the rRNA molecules contain well-defined segments of different evolutionary variability, which in the 16S rRNA molecule are referred to as universal (U), semiconserved (S), and variable (V) regions (Gray, M. W., Sankoff, D., and Cedergren, R. J. (1984) On the evolutionary descent of organisms and organelles: a global phylogeny based on a highly conserved structural core in small subunit ribosomal RNA. Nucleic Acids Res. 12, 5837-5852.). The universal regions are numbered U1-U8 from the 5'-terminus.
  • 16S rDNA 1.5 kilobase fragment refers to any nucleic acid sequence as defined below.
  • Genbank accession n°JN935890.1 (Acholeylasma laidlawii strain Algen 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence, 1578 bp) qqjatgaacgc tggcggcgtg cctaatacat gcaagtc aa cgaagcatct tcggatgcttt
  • 16S rDNA 1.5 kilobase fragment refers also to any nucleic acid sequence having at least 90% of identity to the nucleic acid sequence of SEQ ID N°2.
  • the term “16S rDNA 1.5 kilobase fragment” refers to any nucleic acid sequence having 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% of identity to the nucleic acid sequence of SEQ ID N°2.
  • the method for detecting a mycoplasma 16S rDNA 1.5 kilobase fragment by quantitative PCR is made possible by using degenerate primers.
  • primer is meant an oligonucleotide that binds to a specific sequence of nucleic acid and can be elongated by a polymerase under appropriate conditions.
  • degenerate primer is meant a primer sequence that contains several possible bases in one or more positions. The degeneracy of the primer is the total number of sequence combinations it contains. Thus, degenerate primers are actually mixtures of similar, but not identical primers.
  • a primer pair complementary to the universal regions Ul and U8 are used according to the present invention.
  • These degenerate primers used according to the present invention are called Ul primer and U8 primer (Johansson, K. E., M. U. Heldtander, and B. Pettersson. 1998. Characterization of mycoplasmas by PCR and sequence analysis with universal 16S rDNA primers. Methods Mol Biol 104: 145-165).
  • the sequence of Ul primer is the following sequence:
  • the sequence of U8 primer is the following sequence:
  • W represents A or T.
  • S represents C or G.
  • M represents A or C.
  • K represents G or T.
  • R represents A or G.
  • Y represents C or T.
  • B represents C, G or T.
  • D represents A, G or T.
  • H represents A, C or T.
  • V represents A, C or G.
  • N A, C, G or T.
  • the method according to the invention shares the advantage of using universal 16S rDNA primers that have been validated by Johansson and al. (Johansson, K. E., M. U. Heldtander, and B. Pettersson. 1998. Characterization of mycoplasmas by PCR and sequence analysis with universal 16S rDNA primers. Methods Mol Biol 104: 145-165.) and the Applicant (Audrey J., Florence Tardy F., Allatif O., Grosjean I., Blanquier B., Gerlier D. 2017. Assessing mycoplasma contamination of cell cultures by qPCR using a set of universal primer pairs targeting a 1.5 kb fragment of 16S rRNA genes.
  • the method according to the invention may be used for detecting the presence of mycoplasma (Mollicutes) strains in a sample.
  • mycoplasma Mollicutes
  • the pair of degenerate primers could have been used for the detection of Phytoplasma strains. However, because they detect as well DNA from chloroplasts there are practically useless with plant derived samples.
  • the method according to the invention may be used for detecting the presence of Prokaryote strains in a sample.
  • the sample tested according to the invention for detecting the presence of mycoplasma strains or Prokaryote strains is, for example, a cell culture supernatant sample, food sample, livestock sample, or human sample.
  • the invention refers to a method for detecting any homologue gene of mycoplasma 16S rDNA in a sample comprising contacting said sample with degenerate primers of SEQ ID N°3 and SEQ ID N°4 amplified by qPCR.
  • Prokaryote strains (Tenericutes, incl mollicutes) predicted to be detected with no mismatch with U1/U8 degenerated primers with Silva Test Prime Algorithm (Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glockner FO (2013), The
  • SILVA ribosomal RNA gene database project improved data processing an web-based tools.
  • Nucl. Acids Res. 41 (Dl): D590-D596) and used in the present invention are, for example:
  • Mycoplasma hyopneumoniae 7422 Mycoplasma pneumoniae M129-B7 Mycoplasma bovis CQ-W70
  • Mycoplasma mycoides subsp. mycoides SC str. Gladysdale
  • Mycoplasma mycoides subsp. mycoides
  • the method according to the invention is suitable for the detection of any Prokaryote contamination, especially mycoplasma contamination, in cell cultures.
  • Another application of the method of the present invention may be its use in diagnosis and follow up of contamination in human, livestock, food, or water for example.
  • the method according to the invention comprises the following steps:
  • DNA extracting method from sample can be optimized with internal DNA loading probe.
  • a known amount of DNA loading probe DLP is added to the sample to be tested so as to check the efficiency of DNA recovery measured by DLP-specific qPCR.
  • the DNA loading probe is so quantified by DLP-specific qPCR.
  • DNA extraction yield is determined by DNA loading probe- specific qPCR (step “c").
  • the extraction and purification of DNA is carried out using a commercial kit.
  • the method according to the invention comprises a step of determination of 16S DNA copy number by plotting Cq (cycling quantitation) values on a standard curve obtained by qPCR of an internally deleted 16S rDNA source.
  • the standard curve is obtained by qPCR of an internally deleted 16S rDNA source.
  • the method according to the invention further comprises using a traceable internal PCR positive control.
  • the positive control is a known and traceable 16S rDNA source.
  • the method according to the invention further comprises a step of detecting inhibitors of the PCR contaminating the sample.
  • the method according to the invention further comprises a step of visualizing the 1.5 kilobase size of the amplicon by electrophoresis on agarose gel.
  • the method according to the invention comprises a further step consisting of identifying the mycoplasma (Mollicutes) strain by sequencing of the DNA amplicon.
  • the method according to the invention comprises a further step consisting of identifying the Prokaryote strain by sequencing of the DNA amplicon.
  • the sequence of the DNA amplicon is blasted against a gene sequences database.
  • the gene sequences database may be Genebank. This further step is useful to trace the source of the contamination.
  • the sample tested according to the invention is for example a cell culture supernatant sample, food sample, livestock sample or human sample.
  • the sample is Biosafety Level 2 to Biosafety Level 4 pathogenic sample.
  • biosafety level has its general meaning in the art and refers to a set of biocontainment precautions required to isolate dangerous biological agents in an enclosed laboratory facility.
  • the levels of containment range from the lowest biosafety level 1 (BSL-1) to the highest at level 4 (BSL-4). These levels have been defined in reference documents in the USA (Richmond JY, McKinney RW, Biosafety in Microbiological and Biomedical Laboratories (4th ed.)(1999), ISBN 0-7881-8513-6) and in the European Union (Council Directive 90/679/EEC of 26 November 1990 on the protection of workers from risks related to exposure to biological agents at work, OJ No. L 374, p. 1)
  • the method according to the invention comprises the steps as described in Figure 1.
  • the qPCR technique is detailed below.
  • the template nucleic acid need not be purified. Nucleic acids may be extracted from a sample by routine techniques such as those described in Diagnostic Molecular Microbiology: Principles and Applications (Persing et al. (eds), 1993, American Society for Microbiology, Washington D.C.).
  • PCR typically employs two oligonucleotide primers that bind to a selected target nucleic acid sequence.
  • Primers useful in the present invention include oligonucleotides capable of acting as a point of initiation of nucleic acid synthesis within the target nucleic acid sequence.
  • a primer can be purified from a restriction digest by conventional methods, or it can be produced synthetically. If the template nucleic acid is double- stranded (e.g. DNA), it is necessary to separate the two strands before it can be used as a template in PCR.
  • Strand separation can be accomplished by any suitable denaturing method including physical, chemical or enzymatic means.
  • One method of separating the nucleic acid strands involves heating the nucleic acid until it is predominately denatured (e.g., greater than 50%, 60%, 70%, 80%, 90% or 95% denatured).
  • the heating conditions necessary for denaturing template nucleic acid will depend, e.g., on the buffer salt concentration and the length and nucleotide composition of the nucleic acids being denatured, but typically range from about 90° C. to about 105° C. for a time depending on features of the reaction such as temperature and the nucleic acid length.
  • Denaturation is typically performed for about 30 sec to 4 min (e.g., 1 min to 2 min 30 sec, or 1.5 min). If the double-stranded template nucleic acid is denatured by heat, the reaction mixture is allowed to cool to a temperature that promotes annealing of each primer to its target sequence on the target nucleic acid sequence.
  • the temperature for annealing is usually from about 35° C. to about 65° C. (e.g., about 40° C. to about 60° C; about 45° C. to about 50° C).
  • Annealing times can be from about 10 sec to about 1 min (e.g., about 20 sec to about 50 sec; about 30 sec to about 40 sec).
  • the reaction mixture is then adjusted to a temperature at which the activity of the polymerase is promoted or optimized, i.e., a temperature sufficient for extension to occur from the annealed primer to generate products complementary to the template nucleic acid.
  • a temperature at which the activity of the polymerase is promoted or optimized i.e., a temperature sufficient for extension to occur from the annealed primer to generate products complementary to the template nucleic acid.
  • the temperature should be sufficient to synthesize an extension product from each primer that is annealed to a nucleic acid template, but should not be so high as to denature an extension product from its complementary template (e.g., the temperature for extension generally ranges from about 40° C. to about 80° C. (e.g., about 50° C. to about 70° C; about 60° C).
  • Extension times can be from about 10 sec to about 5 min (e.g., about 30 sec to about 4 min; about 1 min to about 3 min; about 1 min 30 sec to about 2 min).
  • qPCR involves use of a thermostable polymerase.
  • the term "thermostable polymerase” refers to a polymerase enzyme that is heat stable, i.e., the enzyme catalyzes the formation of primer extension products complementary to a template and does not irreversibly denature when subjected to the elevated temperatures for the time necessary to effect denaturation of double- stranded template nucleic acids. Generally, the synthesis is initiated at the 3' end of each primer and proceeds in the 5' to 3' direction along the template strand.
  • Thermostable polymerases have been isolated from Thermus fiavus, T. ruber, T. thermophilus, T. aquaticus, T. lacteus, T. rubens, Bacillus stearothermophilus, and Methanothermus fervidus. Nonetheless, polymerases that are not thermostable also can be employed in PCR assays provided the enzyme is replenished.
  • the polymerase is a Taq polymerase (i.e. Thermus aquaticus polymerase).
  • chain extension reactions generally include 50 mM KC1, 10 mM Tris-HCl (pH 8.3), 15 mM MgC12, 0.001% (w/v) gelatin, 0.5-1.0 ⁇ g denatured template DNA, 50 pmoles of each oligonucleotide primer, 2.5 U of Taq polymerase, and 10% DMSO).
  • the reactions usually contain 150 to 320 ⁇ each of dATP, dCTP, dTTP, dGTP, or one or more analogs thereof.
  • the newly synthesized strands form a double-stranded molecule that can be used in the succeeding steps of the reaction.
  • the steps of strand separation, annealing, and elongation can be repeated as often as needed to produce the desired quantity of amplification products corresponding to the target nucleic acid sequence molecule.
  • the limiting factors in the reaction are the amounts of primers, thermostable enzyme, and nucleoside triphosphates present in the reaction.
  • the cycling steps i.e., denaturation, annealing, and extension
  • the number of cycling steps will depend, e.g., on the nature of the sample. If the sample is a complex mixture of nucleic acids, more cycling steps will be required to amplify the target sequence sufficient for detection.
  • the cycling steps are repeated at least about 20 times, but may be repeated as many as 40, 60, or even 100 times.
  • Quantitative PCR is typically carried out in a thermal cycler with the capacity to illuminate each sample with a beam of light of a specified wavelength and detect the fluorescence emitted by the excited fluorophore.
  • the thermal cycler is also able to rapidly heat and chill samples, thereby taking advantage of the physicochemical properties of the nucleic acids and thermal polymerase.
  • SYBR® Green I SYBR® Green I is the most commonly used dye for non-specific detection. It is a double- stranded DNA intercalating dye, that fluoresces once bound to the DNA.
  • a pair of specific primers is required to amplify the target with this chemistry.
  • the amount of dye incorporated is proportional to the amount of generated target.
  • the dye emits at 520 nm and fluorescence emitted can be detected and related to the amount of target.
  • the advantage of this technique is that the SYBR®-Green-I will bind to any amplified dsDNA. However, consequently, primer dimers or unspecific products will be also detected, thus introducing a possible bias in the quantification.
  • it is essential to check for the specificity of the system by running a meltcurve at the end of the PCR run.
  • the principle is that every product has a different dissociation temperature, depending of the size and base contents, so it is still possible to check the number of products amplified.
  • High Resolution Melting dyes High Resolution Melting dyes (HRM dyes): High Resolution Meltcurve analysis is a newly emerging technology, which characterizes nucleic acid samples based on their dissociation behaviour. It combines the principle of intercalating dyes, meltcurve analyses and the application of specific statistical analyses. HRM uses the fundamental property of the separation of the two strands of DNA with heat (melting), and the monitoring of this melting with a fluorescent dye.
  • HRM dyes do not inhibit PCR at high concentration.
  • the dye can consequently saturate the amplified target dsDNA and fluoresces.
  • Melting temperature of a dsDNA target depends on GC content, length, and sequence. Due to the high sensitivity of HRM dyes, even a single base change will induce differences in the melting curve, and consequently in fluorescence (Erali M. et al., 2008). This emerging method is less expensive and as precise as probe-based methods.
  • the main HRM dyes available are EvaGreen, LCGreen®, SYTO® 9 and BEBO.
  • TaqMan® probes Double-Dye probes: TaqMan® probes, also called Double-Dye Oligonucleotides, Double-Dye Probes, or Dual- Labelled probes, are the most widely used type of probes and are often the method of choice for scientists who have just started using Real-Time PCR. They were developed by Roche (Basel, Switzerland) and ABI (Foster City, USA) from an assay that originally used a radio- labelled probe (Holland et al. 1991), which consisted of a single- stranded probe sequence that was complementary to one of the strands of the amplicon. A fluorophore is attached to the 5' end of the probe and a quencher to the 3' end.
  • the fluorophore is excited by the machine and passes its energy, via FRET (Fluorescence Resonance Energy Transfer) to the quencher.
  • FRET Fluorescence Resonance Energy Transfer
  • the FRET pair has been FAM as the fluorophore and TAMRA as the quencher.
  • FAM does not fluoresce as it passes its energy onto TAMRA.
  • TAMRA fluorescence is detected at a different wavelength to FAM, the background level of FAM is low.
  • the probe binds to the amplicon during each annealing step of the PCR.
  • the Taq polymerase When the Taq polymerase extends from the primer which is bound to the amplicon, it displaces the 5' end of the probe, which is then degraded by the 5 '-3' exonuclease activity of the Taq polymerase. Cleavage continues until the remaining probe melts off the amplicon. This process releases the fluorophore and quencher into solution, spatially separating them (compared to when they were held together by the probe). This leads to an irreversible increase in fluorescence from the FAM and a decrease in the TAMRA.
  • LNA® Double-Dye probes LNA® (Locked Nucleic Acid) was developed by Exiqon® (Vedbaek, Denmark). LNA® changes the conformation of the helix and increases the stability of the duplex. The integration of LNA® bases into Double-Dye Oligonucleotide probes, opens up great opportunities to improve techniques requiring high affinity probes as specific as possible, like SNP detection, expression profiling and in situ hybridization. LNA® is a bicyclic RNA analogue, in which the ribose moiety in the sugar-phosphate backbone is structurally constrained by a methylene bridge between the 2' -oxygen and the 4' -carbon atoms.
  • LNA® bases changes the conformation of the double helix from the B to A type (Ivanova A. et al., 2007). LNA® conformation allows a much better stacking and therefore a higher stability.
  • Tm melting Temperature
  • Molecular Beacon probes are probes that contain a stem-loop structure, with a fluorophore and a quencher at their 5' and 3' ends, respectively.
  • the stem is usually 6 bases long, should mainly consist of C's and G's, and holds the probe in the hairpin configuration (Li Y. et al., 2008).
  • the 'stem' sequence keeps the fluorophore and the quencher in close vicinity, but only in the absence of a sequence complementary to the 'loop' sequence. As long as the fluorophore and the quencher are in close proximity, the quencher absorbs any photons emitted by the fluorophore.
  • This phenomenon is called collisional (or proximal) quenching.
  • the Beacon unfolds and hybridizes to the target, the fluorophore is then displaced from the quencher, so that it can no longer absorb the photons emitted by the fluorophore, and the probe starts to fluoresce.
  • the amount of signal is proportional to the amount of target sequence, and is measured in real time to allow quantification of the amount of target sequence (Takacs T. et al., 2008).
  • the increase in fluorescence that occurs is reversible, (unlike TaqMan® probes), as there is no cleavage of the probe, that can close back into the hairpin structure at low temperature.
  • the stem structure adds specificity to this type of probe, because the hybrid formed between the probe and target has to be stronger than the intramolecular stem association.
  • Good design of Molecular Beacons can give good results, however the signal can be poor, as no physical separation of fluorophore from quencher occurs.
  • Wavelength-Shifting Molecular Beacons are brighter than standard Molecular Beacons due to an enhanced fluorescence intensity of the emitter fluorophore.
  • These probes contain a harvester fluorophore that absorbs strongly in the wavelength range of the monochromatic light source, an emitter fluorophore of the desired emission color, and a non-fluorescent (dark) quencher.
  • the probes are non- fluorescent, whereas in the presence of targets, they fluoresce, not in the emission range of the harvester fluorophore, that absorbs the light, but rather in the emission range of the emitter fluorophore. This shift in emission spectrum is due to the transfer of the absorbed energy from the harvester fluorophore to the emitter fluorophore by FRET, which only takes place in probes that are bound to the targets.
  • Wavelength-Shifting Molecular Beacons are substantially brighter than conventional Molecular Beacons that cannot efficiently absorb energy from the available monochromatic light source (Tyagi S. et al., 2000).
  • Scorpions® primers are suitable for both quantitative Real-Time PCR and genotyping/end-point analysis of specific DNA targets. They are PCR primers with a "stem-loop" tail consisting of a specific probe sequence, a fluorophore and a quencher. The "stem-loop" tail is separated from the PCR primer sequence by a "PCR blocker", a chemical modification that prevents the Taq polymerase from copying the stem loop sequence of the Scorpions® primer. Such read-through would lead to non-specific opening of the loop, causing a non-specific fluorescent signal.
  • the hairpin loop is linked to the 5' end of a primer via a PCR blocker.
  • the specific probe sequence After extension of the primer during PCR amplification, the specific probe sequence is able to bind to its complement within the same strand of DNA. This hybridization event opens the hairpin loop so that fluorescence is no longer quenched and an increase in signal is observed. Unimolecular probing is kinetically favorable and highly efficient. Covalent attachment of the probe to the target amplicon ensures that each probe has a target in the near vicinity. Enzymatic cleavage is not required, thereby reducing the time needed for signaling compared to TaqMan® probes, which must bind and be cleaved before an increase in fluorescence is observed. There are three types of Scorpions® primers.
  • Standard Scorpions® which consist of a bi-labelled probe with a fluorescent dye at the 5' end and an internal non-fluorescent quencher.
  • FRET Scorpions® for use on a LightCycler® system. As the capillary system will only excite at 470 nm (FAM absorption wavelength) it is necessary to incorporate a FAM within the stem. A ROX is placed at the 5 'end of the Scorpions® primer, FAM is excited and passes its energy onto the ROX.
  • Duplex Scorpions® have also been developed to give much better signal intensity than the normal Scorpions® format. In Standard Scorpions® the quencher and fluorophore remain within the same strand of DNA and some quenching can occur even in the open form. In the Duplex Scorpions® the quencher is on a different oligonucleotide and physical separation between the quencher and fluorophore is greatly increased, reducing the quenching when the probe is bound to the target.
  • Hybridization probes also called FRET probes: Roche has developed hybridization probes (Caplin et al. 1999) for use with their LightCycler®. Two probes are designed to bind adjacent to one another on the amplicon. One has a 3' label of FAM, whilst the other has a 5' LC dye, LC red 640 or 705. When the probes are not bound to the target sequence, the fluorescent signal from the reporter dye is not detected. However, when the probes hybridize to the target sequence during the PCR annealing step, the close proximity of the two fluorophores allows energy transfer from the donor to the acceptor dye, resulting in a fluorescent signal that is detected.
  • TaqMan® MGB® probes have been developed by Epoch Biosciences (Bothell, USA) and Applied Biosystems (Foster City, USA). They bind to the minor groove of the DNA helix with strong specificity and affinity. When the TaqMan® MGB® probe is complemented with DNA, it forms a very stable duplex with DNA. The probe carries the MGB® moiety at the 3' end. The MGB strongly increases the probe Tm , allowing shorter, hence more specific designs. The probe performs particularly well with A / T rich regions, and is very successful for SNP detection (Walburger et al., 2001).
  • MGB Eclipse® probes MGB Eclipse® probes also known as QuantiProbes, have originally been developed by Epoch Biosciences (Bothell, USA). MGB Eclipse® probes carry a minor groove binder moiety that allows the use of short probes for very high specificity. These are short linear probes that have a minor groove binder and a quencher on the 5' end and a fluorophore on the 3'end. This is the opposite orientation to TaqMan® MGB® probes and it is thought that the minor groove binder prevents the exonuclease activity of the Taq polymerase from cleaving the probe.
  • the quencher is a Non Fluorescent Quencher also known as Eclipse Dark Quencher. Quenching occurs when the random coiling of the probe in the free form brings the quencher and the fluorophore close to another. The probe is straightened out when bound to its target and quenching is decreased, leading to an increase in fluorescent signal.
  • the technologies that have been discussed above are the most widely used today, but numerous other technologies have occurred in publications, or are available on the market, such as: Resonsense probes, Light-up probes, HyBeacon® probes, LUX primers, Yin-yang probes, or Amplifluor®. You can contact us for more information on any of them.
  • thermocyclers typically involve a format of glass capillaries, plastics tubes, 96-well plates or 384-wells plates.
  • the thermocycler also involve a software analysis.
  • Taq polymerase A HotStart Taq polymerase is inactive at low temperatures (room temperature). Heating at 95 °C for several - usually 5 to 10 - minutes activates the enzyme, and the amplification can begin once the primers are annealed. The enzyme is not active until the entire DNA is denatured. Two major HotStart modifications exist, the antibody-blocked Taq and the chemically- blocked Taq. The antibody-blocked Taq is inactive because it is bound to a thermolabile inhibitor that is denatured during the initial step of PCR. The chemically-blocked Taq provides one clear advantage over the antibody-blocked Taq, as it is completely inactive at 60 °C, (the hybridization temperature of primers), thus preventing the formation of non- specific amplification and reducing primer dimer formation.
  • dNTps / dUTps Some kits contain a blend of dNTPs and dUTPs, other ones contain only dNTPs. Using only dNTPs increases the sensitivity, the reason being that the Taq incorporates more easily dNTPs than dUTPs. However, using a mix containing dUTPs brings security to the assay, in case of contamination from a previous PCR product. Thanks to the UNG activity in association with incorporated dUTPs, this contamination can be eliminated.
  • the Uracil-N-Glycosylase is an enzyme that hydrolyses all single-stranded and double-stranded DNA containing dUTPs. Consequently, if all PCR amplifications are performed in the presence of a dNTPs/dUTPs blend, by carrying a UNG step before every run it is possible to get rid of any previous PCR product.
  • ROX reference dye Some thermocyclers require MasterMix containing ROX dye for normalization. This is the case for the ABI and Eppendorf machines, and optional on the Stratagene machines. If you work with such machines, it is easier to work with the ROX dye already incorporated in the MasterMix rather than adding it manually. It guarantees a higher level of reproducibility and homogeneity of your assays.
  • Fluorescein For iCycler iQ®, My iQ® and iQ5 machines (BioRad thermocyclers), the normalization method for SYBR® Green assay uses Fluorescein to create a "virtual background". As in the case for the ROX, it is better and easier to use a MasterMix that contains pre-diluted Fluorescein, guaranteeing higher reproducibility and homogeneity of your assays.
  • MgCl 2 is necessary for the Taq activity. MgCl concentration in MasterMixes is optimized according to the amount of Taq and also the buffer composition. However, it may be necessary sometimes to add MgC12 and most MasterMixes include an additional tube of MgC12.
  • Some buffers also include an inert colored dye, to enable visualization of the buffer when loading in the wells. This colored dye has no effect on the sensitivity of the assay and is a convenient working tool. Note that such mixes, in combination with white plastic plates, provide better levels of fluorescence and a really easy way of working.
  • primers are designed using a designing software (for example Beacon DesignerTM).
  • Beacon DesignerTM Most thermocycler softwares now offer tools to help in designing primers with the best characteristics.
  • Some of the best softwares are Beacon Designer, Primer Express, and DNA Star. Some other tools are freely available on the web, for example:
  • qPCR involves the preparation of a standard curve for each amplified target nucleic acid sequence. Preparing a standard curve can indeed provide a good idea of the performance of the qPCR and thus serves as a quality control.
  • the standard curve should cover the complete range of expected expression. Using standard material the standard curve should include at least 5 points of dilution, each of them in duplicate (at least). The 10-fold or 2-fold dilution range should cover the largest range of expression levels. Plotting these points on a standard curve, will determine the linearity, the efficiency, the sensitivity and the reproducibility of the assay.
  • the standard curve is prepared from a "built on purpose" plasmid DNA containing the genomic DNA target.
  • genomic DNA sample refers to a genomic DNA sample prepared from a DNA preparation. Methods for DNA purification are well known in the art.
  • the genomic DNA may be prepared from a cell that is of the same organism than the cell that is used for preparing the nucleic acid sample of the invention (i.e. a human cell).
  • the cell from which the genomic sample is prepared must present the same ploidy than the cell used for preparing the nucleic acid sample of the invention; i.e. the cells present the same chromosomal abnormalities (e.g. in case of cancer cells).
  • FIGURE Another aspect of the present invention relates to a kit for detecting mycoplasma 16S rDNA 1.5 kilobase fragment in a sample, comprising degenerate primers of SEQ ID N°3 and SEQ ID N°4, a thermal cycler, and reagents for performing the quantitative polymerase chain reaction.
  • the invention will be further illustrated by the following figure and example. However, these example and figure should not be interpreted in any way as limiting the scope of the present invention.
  • FIGURE
  • Figure 1 Flow diagram of the method for detecting mycoplasma (Mollicutes) 16S rDNA 1.5 kilobase fragment amplified by quantitative PCR or qPCR.
  • the method for detecting mycoplasma 16S rDNA 1.5 kilobase fragment amplified by quantitative polymerase chain reaction is described with a flow diagram (figure 1).
  • the first step of the method consists of DNA extraction from an unknown sample (e.g. cell free supernatant) with addition of DNA loading probe (DLP).
  • DLP DNA loading probe
  • 16S rDNA quantitative PCR using universal U1/U8 primers SED ID N°3 and SED ID N°4 respectively.
  • the efficiency of DNA recovery is checked: the DNA loading probe is quantified by DLP- specific qPCR in order to determine DNA extraction yield.
  • step 3 can be carried out. If it is concluded the yield of DLP recovery is less than 3%, method has to be started again from the first step.
  • the third step consists in analysing the melting curve of the final amplicon as a first filter for presence of the 16S rDNA amplicons in the sample. If the melting curve is identical to water control, mycoplasma is not detected. If the melting curve is a typical 16S rDNA melting curve, there is mycoplasma in the sample and the method can be continued with the fourth step. If the melting curve is atypical, the method has to be continued directly with the fifth step.
  • the copy number of 16s rDNA is determined by plotting Cq (cycling quantitation) values on a standard curve obtained by qPCR of an internally deleted 16S rDNA source (step 4).
  • the fifth step consists of the visualization of the length of the amplicons by electrophoresis on agarose gel. If only primer/dimer DNA band is detected (i.e 1.5 kb DNA band is not detected), there is no mycoplasma detected in the sample. If the 1.5 kb DNA band is detected, there is mycoplasma is the sample and the method can be continued with the sixth step. If the 0.9 kb DNA band of the positive 16S rDNA control is detected, method has to be started again from the first step because it reflects accidental contamination when preparing the sample.
  • the sixth step comprising DNA sequencing and blasting against Genebank, is carried out when there is mycoplasma in the sample, i.e. a 1.5 kb DNA band is detected during the fifth step.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un procédé de détection d'un fragment de 1,5 kilobase d'ADNr de mycoplasma 16S amplifié par PCR quantitative. L'une des restrictions les plus critiques de la PCRq est la longueur du fragment d'ADN à amplifier. Les procédés existants de PCRq ne permettent pas l'amplification de longs fragments d'ADN. Les inventeurs de la présente invention font preuve pour la première fois de l'amplification d'un fragment de 1,5 kilobase d'ADNr de mycoplasma 16S en utilisant la PCRq sur la base d'une réaction en chaîne de la polymérase en temps réel. En particulier, la présente invention concerne un procédé de détection universelle et de quantification d'un fragment de 1,5 kilobase d'ADNr de mycoplasma 16S dans un échantillon comprenant la mise en contact dudit échantillon avec des amorces dégénérées amplifiées par PCR ou PCRq quantitative et en utilisant une sonde de charge d'ADN.
PCT/EP2017/058928 2016-04-14 2017-04-13 Procédé de détection universelle et quantification d'adnr de mycoplasma (mollicutes) 16s par réaction en chaîne de la polymérase quantitative en amplifiant un fragment de 1,5 kilobase Ceased WO2017178587A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16305435 2016-04-14
EP16305435.6 2016-04-14

Publications (2)

Publication Number Publication Date
WO2017178587A1 true WO2017178587A1 (fr) 2017-10-19
WO2017178587A9 WO2017178587A9 (fr) 2018-01-04

Family

ID=56121006

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2017/058928 Ceased WO2017178587A1 (fr) 2016-04-14 2017-04-13 Procédé de détection universelle et quantification d'adnr de mycoplasma (mollicutes) 16s par réaction en chaîne de la polymérase quantitative en amplifiant un fragment de 1,5 kilobase

Country Status (1)

Country Link
WO (1) WO2017178587A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108893548A (zh) * 2018-07-23 2018-11-27 安徽古生物科技有限公司 用于检测支原体的荧光定量pcr引物、检测方法及应用
CN110904251A (zh) * 2019-11-28 2020-03-24 温氏食品集团股份有限公司 一种用于鸭支原体检测的引物组及试剂盒
CN115873822A (zh) * 2020-10-07 2023-03-31 武汉爱博泰克生物科技有限公司 用于探针法qPCR的Taq DNA聚合酶突变体
RU2831277C1 (ru) * 2023-12-27 2024-12-03 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ выявления ДНК микроорганизмов класса Mollicutes в крови и других биоматериалах методом ПЦР-РВ
WO2025114394A1 (fr) * 2023-11-27 2025-06-05 Sanofi Procédé de détection de micro-organismes

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
WO2001071033A2 (fr) * 2000-03-20 2001-09-27 Forinnova As Procede de determination de la duplication ou de la suppression d'un adn genomique heterozygote
US20110104692A1 (en) * 2009-11-03 2011-05-05 Genetic Analysis As Oligonucleotide Primers

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683202B1 (fr) 1985-03-28 1990-11-27 Cetus Corp
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683195B1 (fr) 1986-01-30 1990-11-27 Cetus Corp
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
WO2001071033A2 (fr) * 2000-03-20 2001-09-27 Forinnova As Procede de determination de la duplication ou de la suppression d'un adn genomique heterozygote
US20110104692A1 (en) * 2009-11-03 2011-05-05 Genetic Analysis As Oligonucleotide Primers

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
"Society for Microbiology", 1993, WASHINGTON D.C, article "Diagnostic Molecular Microbiology: Principles and Applications"
ARCENAS R C ET AL: "A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, ELSEVIER, AMSTERDAM, NL, vol. 54, no. 3, 1 March 2006 (2006-03-01), pages 169 - 175, XP028005607, ISSN: 0732-8893, [retrieved on 20060301], DOI: 10.1016/J.DIAGMICROBIO.2005.08.006 *
AUDREY J.; FLORENCE TARDY F.; ALLATIF O.; GROSJEAN I.; BLANQUIER B.; GERLIER D, METHODS MOL BIOL, 2017
DREXLER, H. G.; C. C. UPHOFF: "Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention", CYTOTECHNOLOGY, vol. 39, 2002, pages 75 - 90
GRAY, M. W.; SANKOFF, D.; CEDERGREN, R. J.: "On the evolutionary descent of organisms and organelles: a global phylogeny based on a highly conserved structural core in small subunit ribosomal RNA", NUCLEIC ACIDS RES, vol. 12, 1984, pages 5837 - 5852
HUANG, L.; X. HU; M. ZHOU; Y. YANG; J. QIAO; D. WANG; J. YU; Z. CUI; Z. ZHANG; X. E. ZHANG: "Rapid detection of New Delhi metallo-beta-lactamase gene and variants coding for carbapenemases with different activities by use of a PCR-based in vitro protein expression method", J CLIN MICROBIOL, vol. 52, 2014, pages 1947 - 1953
JOHANSSON ET AL: "Characterisation of mycoplasmas by PCR and sequence analysis with universal primer 16S rDNA primers", METHODS IN MOLECULAR BIOLOGY, vol. 104, 1 January 1998 (1998-01-01), pages 145 - 165, XP009190925 *
JOHANSSON, K. E.; M. U. HELDTANDER; B. PETTERSSON: "Characterization of mycoplasmas by PCR and sequence analysis with universal 16S rDNA primers", METHODS MOL BIOL, vol. 104, 1998, pages 145 - 165
LI, H.; J. CHEN; M. ZHOU; X. GENG; J. YU; W. WANG; X. E. ZHANG; H. WEI: "Rapid detection of Mycobacterium tuberculosis and pyrazinamide susceptibility related to pncA mutations in sputum specimens through an integrated gene-to-protein function approach", J CLIN MICROBIOL, vol. 52, 2014, pages 260 - 267
OLARERIN-GEORGE; A. O.; J. B. HOGENESCH: "Assessing the prevalence of mycoplasma contamination in cell culture via a survey of NCBI's RNA-seq archive", NUCLEIC ACIDS RES, vol. 43, 2015, pages 2535 - 2542
QUAST C; PRUESSE E; YILMAZ P; GERKEN J; SCHWEER T; YARZA P; PEPLIES J; GLOCKNER FO: "The SILVA ribosomal RNA gene database project: improved data processing an web-based tools", NUCL. ACIDS RES, vol. 41, no. DL, 2013, pages D590 - D596
RICHMOND JY; MCKINNEY RW: "Biosafety in Microbiological and Biomedical", 1999
UPHOFF CORD C ET AL: "Comparative PCR analysis for detection of mycoplasma infections in continuous cell lines", IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY. ANIMAL, SPRINGER US, NEW YORK, vol. 38, no. 2, 1 February 2002 (2002-02-01), pages 79 - 85, XP002541349, ISSN: 1071-2690 *
YOUNG, L.; J. SUNG; G. STACEY; J. R. MASTERS: "Detection of Mycoplasma in cell cultures", NAT PROTOC, vol. 5, 2010, pages 929 - 934

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108893548A (zh) * 2018-07-23 2018-11-27 安徽古生物科技有限公司 用于检测支原体的荧光定量pcr引物、检测方法及应用
CN110904251A (zh) * 2019-11-28 2020-03-24 温氏食品集团股份有限公司 一种用于鸭支原体检测的引物组及试剂盒
CN115873822A (zh) * 2020-10-07 2023-03-31 武汉爱博泰克生物科技有限公司 用于探针法qPCR的Taq DNA聚合酶突变体
WO2025114394A1 (fr) * 2023-11-27 2025-06-05 Sanofi Procédé de détection de micro-organismes
RU2831277C1 (ru) * 2023-12-27 2024-12-03 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ выявления ДНК микроорганизмов класса Mollicutes в крови и других биоматериалах методом ПЦР-РВ

Also Published As

Publication number Publication date
WO2017178587A9 (fr) 2018-01-04

Similar Documents

Publication Publication Date Title
US12378601B2 (en) Multiplex Y-STR analysis
Seki et al. Loop-mediated isothermal amplification method targeting the lytA gene for detection of Streptococcus pneumoniae
Letertre et al. Evaluation of the performance of LNA and MGB probes in 5′-nuclease PCR assays
US20150037791A1 (en) Methods and kits for multiplex amplification of short tandem repeat loci
WO2012145557A1 (fr) Compositions et procédés pour détecter et identifier des souches de salmonella enterica
WO2017178587A1 (fr) Procédé de détection universelle et quantification d'adnr de mycoplasma (mollicutes) 16s par réaction en chaîne de la polymérase quantitative en amplifiant un fragment de 1,5 kilobase
CN105755134B (zh) 一种内切酶介导的实时多交叉置换核酸扩增技术及应用
CA2925212C (fr) Detection de polymorphisme mononucleotidique au moyen de sondes d'hydrolyse dotees d'une structure en epingle a cheveux a l'extremite 3'
EP4081666B1 (fr) Compositions et méthodes de détection de staphylococcus aureus résistant à la méticilline
EP3068897B1 (fr) Détection d'un polymorphisme mononucléotidique en utilisant une amorce de chevauchement et une sonde de fusion
US20060240427A1 (en) Method for the detection of pathogenic gram positive bacteria from the genera staphylococcus, enterococcus and streptococcus
JP5900908B2 (ja) 一塩基反復多型解析方法及び一塩基多型解析方法
EP3227459A1 (fr) Compositions et procédés de détection de staphylococcus aureus résistant à la méthicilline contenant mecc
Overbergh et al. Quantitative Polymerase Chain Reaction
EP3006565A1 (fr) Selektiver nachweis von bordetella-spezies
US7267943B1 (en) Methods for detecting bacteriophage MS2
Bae et al. Molecular genetic analysis of wetland soils
JP4238319B2 (ja) マイコプラズマの検出方法
EP3325671A1 (fr) Procédés d'utilisation de longs polynucléotides d'adnsb comme amorces dans des dosages par pcr
WO2011008942A2 (fr) Détection quantitative simultanée à multiples amorces de clostridium difficile
FI126289B (en) Method for detecting the presence of a hypervirulent strain of Clostridium difficile
US9267178B2 (en) Detection and differentiation of demodex mites
US7642082B1 (en) Methods for determining the presence of staphylococcal enterotoxin A gene in a sample
Ravnikar et al. Real-time PCR.
Marttila et al. Molecular detection of resistance to antituberculous therapy

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17718501

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17718501

Country of ref document: EP

Kind code of ref document: A1